Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl) ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain

Mukesh Pandey, Timothy R DeGrado, Kun Qian, Mark S. Jacobson, Clinton E. Hagen, Richard I. Duclos, S. John Gatley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

N-Acylethanolamines are lipid signaling molecules found throughout the plant and animal kingdoms. The best-known mammalian compound of this class is anandamide, Narachidonoylethanolamine, one of the endogenous ligands of cannabinoid CB1 and CB2 receptors. Signaling by N-acylethanolamines is terminated by release of the ethanolamine moiety by hydrolyzing enzymes such as fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing amidase (NAAA). Herein, we report the design and synthesis of N-(16-18F-fluorohexadecanoyl)- ethanolamine (18F-FHEA) as a positron emission tomography (PET) probe for imaging the activity of N-acylethanolamine hydrolyzing enzymes in the brain. Following intravenous administration of 18F-FHEA in Swiss Webster mice, 18F-FHEA was extracted from blood by the brain and underwent hydrolysis at the amide bond and incorporation of the resultant 18F-fluorofatty acid into complex lipid pools. Pretreatment of mice with the FAAH inhibitor URB-597 (1 mg/kg IP) resulted in significantly slower 18F-FHEA incorporation into lipid pools, but overall 18F concentrations in brain regions were not altered. Likewise, pretreatment with a NAAA inhibitor, (S)-N-(2-oxo-3-oxytanyl)biphenyl-4-carboxamide (30 mg/kg IV), did not significantly affect the uptake of 18F-FHEA in the brain. Although evidence was found that 18F-FHEA behaves as a substrate of FAAH in the brain, the lack of sensitivity of brain uptake kinetics to FAAH inhibition discourages its use as a metabolically trapped PET probe of N-acylethanolamine hydrolyzing enzyme activity. (Chemical Equation Presented).

Original languageEnglish (US)
Pages (from-to)793-802
Number of pages10
JournalACS Chemical Neuroscience
Volume5
Issue number9
DOIs
StatePublished - Sep 17 2014

Fingerprint

Positron emission tomography
Ethanolamine
Metabolism
Positron-Emission Tomography
Brain
amidase
Lipids
Enzymes
Cannabinoid Receptor CB2
Cannabinoid Receptor CB1
Enzyme activity
N-acylethanolamines
Amides
Intravenous Administration
Hydrolysis
Animals
Blood
Ligands
Imaging techniques
Molecules

Keywords

  • F-FHEA
  • Endocannabinoids
  • N-(16-F-fluorohexadecanoyl)ethanolamine
  • N-acylethanolamines
  • PET

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Physiology
  • Cognitive Neuroscience

Cite this

Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl) ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain. / Pandey, Mukesh; DeGrado, Timothy R; Qian, Kun; Jacobson, Mark S.; Hagen, Clinton E.; Duclos, Richard I.; Gatley, S. John.

In: ACS Chemical Neuroscience, Vol. 5, No. 9, 17.09.2014, p. 793-802.

Research output: Contribution to journalArticle

@article{b55ffa23a9ca4b47aa4ffa94f2dc51fe,
title = "Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl) ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain",
abstract = "N-Acylethanolamines are lipid signaling molecules found throughout the plant and animal kingdoms. The best-known mammalian compound of this class is anandamide, Narachidonoylethanolamine, one of the endogenous ligands of cannabinoid CB1 and CB2 receptors. Signaling by N-acylethanolamines is terminated by release of the ethanolamine moiety by hydrolyzing enzymes such as fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing amidase (NAAA). Herein, we report the design and synthesis of N-(16-18F-fluorohexadecanoyl)- ethanolamine (18F-FHEA) as a positron emission tomography (PET) probe for imaging the activity of N-acylethanolamine hydrolyzing enzymes in the brain. Following intravenous administration of 18F-FHEA in Swiss Webster mice, 18F-FHEA was extracted from blood by the brain and underwent hydrolysis at the amide bond and incorporation of the resultant 18F-fluorofatty acid into complex lipid pools. Pretreatment of mice with the FAAH inhibitor URB-597 (1 mg/kg IP) resulted in significantly slower 18F-FHEA incorporation into lipid pools, but overall 18F concentrations in brain regions were not altered. Likewise, pretreatment with a NAAA inhibitor, (S)-N-(2-oxo-3-oxytanyl)biphenyl-4-carboxamide (30 mg/kg IV), did not significantly affect the uptake of 18F-FHEA in the brain. Although evidence was found that 18F-FHEA behaves as a substrate of FAAH in the brain, the lack of sensitivity of brain uptake kinetics to FAAH inhibition discourages its use as a metabolically trapped PET probe of N-acylethanolamine hydrolyzing enzyme activity. (Chemical Equation Presented).",
keywords = "F-FHEA, Endocannabinoids, N-(16-F-fluorohexadecanoyl)ethanolamine, N-acylethanolamines, PET",
author = "Mukesh Pandey and DeGrado, {Timothy R} and Kun Qian and Jacobson, {Mark S.} and Hagen, {Clinton E.} and Duclos, {Richard I.} and Gatley, {S. John}",
year = "2014",
month = "9",
day = "17",
doi = "10.1021/cn400214j",
language = "English (US)",
volume = "5",
pages = "793--802",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Synthesis and preliminary evaluation of N-(16-18F-fluorohexadecanoyl) ethanolamine (18F-FHEA) as a PET probe of N-acylethanolamine metabolism in mouse brain

AU - Pandey, Mukesh

AU - DeGrado, Timothy R

AU - Qian, Kun

AU - Jacobson, Mark S.

AU - Hagen, Clinton E.

AU - Duclos, Richard I.

AU - Gatley, S. John

PY - 2014/9/17

Y1 - 2014/9/17

N2 - N-Acylethanolamines are lipid signaling molecules found throughout the plant and animal kingdoms. The best-known mammalian compound of this class is anandamide, Narachidonoylethanolamine, one of the endogenous ligands of cannabinoid CB1 and CB2 receptors. Signaling by N-acylethanolamines is terminated by release of the ethanolamine moiety by hydrolyzing enzymes such as fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing amidase (NAAA). Herein, we report the design and synthesis of N-(16-18F-fluorohexadecanoyl)- ethanolamine (18F-FHEA) as a positron emission tomography (PET) probe for imaging the activity of N-acylethanolamine hydrolyzing enzymes in the brain. Following intravenous administration of 18F-FHEA in Swiss Webster mice, 18F-FHEA was extracted from blood by the brain and underwent hydrolysis at the amide bond and incorporation of the resultant 18F-fluorofatty acid into complex lipid pools. Pretreatment of mice with the FAAH inhibitor URB-597 (1 mg/kg IP) resulted in significantly slower 18F-FHEA incorporation into lipid pools, but overall 18F concentrations in brain regions were not altered. Likewise, pretreatment with a NAAA inhibitor, (S)-N-(2-oxo-3-oxytanyl)biphenyl-4-carboxamide (30 mg/kg IV), did not significantly affect the uptake of 18F-FHEA in the brain. Although evidence was found that 18F-FHEA behaves as a substrate of FAAH in the brain, the lack of sensitivity of brain uptake kinetics to FAAH inhibition discourages its use as a metabolically trapped PET probe of N-acylethanolamine hydrolyzing enzyme activity. (Chemical Equation Presented).

AB - N-Acylethanolamines are lipid signaling molecules found throughout the plant and animal kingdoms. The best-known mammalian compound of this class is anandamide, Narachidonoylethanolamine, one of the endogenous ligands of cannabinoid CB1 and CB2 receptors. Signaling by N-acylethanolamines is terminated by release of the ethanolamine moiety by hydrolyzing enzymes such as fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing amidase (NAAA). Herein, we report the design and synthesis of N-(16-18F-fluorohexadecanoyl)- ethanolamine (18F-FHEA) as a positron emission tomography (PET) probe for imaging the activity of N-acylethanolamine hydrolyzing enzymes in the brain. Following intravenous administration of 18F-FHEA in Swiss Webster mice, 18F-FHEA was extracted from blood by the brain and underwent hydrolysis at the amide bond and incorporation of the resultant 18F-fluorofatty acid into complex lipid pools. Pretreatment of mice with the FAAH inhibitor URB-597 (1 mg/kg IP) resulted in significantly slower 18F-FHEA incorporation into lipid pools, but overall 18F concentrations in brain regions were not altered. Likewise, pretreatment with a NAAA inhibitor, (S)-N-(2-oxo-3-oxytanyl)biphenyl-4-carboxamide (30 mg/kg IV), did not significantly affect the uptake of 18F-FHEA in the brain. Although evidence was found that 18F-FHEA behaves as a substrate of FAAH in the brain, the lack of sensitivity of brain uptake kinetics to FAAH inhibition discourages its use as a metabolically trapped PET probe of N-acylethanolamine hydrolyzing enzyme activity. (Chemical Equation Presented).

KW - F-FHEA

KW - Endocannabinoids

KW - N-(16-F-fluorohexadecanoyl)ethanolamine

KW - N-acylethanolamines

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84923256184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923256184&partnerID=8YFLogxK

U2 - 10.1021/cn400214j

DO - 10.1021/cn400214j

M3 - Article

C2 - 25003845

AN - SCOPUS:84923256184

VL - 5

SP - 793

EP - 802

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 9

ER -